Overview

68Ga-NOTA-RM26 PET/CT in Breast Tumor Patients

Status:
Unknown status

Trial end date:
2018-10-01

Target enrollment:

Participant gender:

Summary

This is an open-label positron emission tomography/computed tomography(PET/CT) study to investigate the diagnostic performance and evaluation efficacy of 68Ga-NOTA-RM26 in breast tumor patients. 1.85 MBq per kilogram body weight of 68Ga-NOTA-RM26A will be injected intravenously. Visual and semiquantitative method will be used to assess the PET/CT images.

Phase:

Early Phase 1

Details

Lead Sponsor:

Peking Union Medical College Hospital

Treatments:

68Ga-NOTA-RM26